跳转至内容
Merck
CN

SML0033

伊托必利 盐酸盐

≥98% (HPLC), dopamine D2-receptor antagonist, powder

别名:

N- [ [4- [2-(二甲氨基)乙氧基] 苯基] 甲基]-3,4-二甲氧基苯甲酰胺盐酸盐, N- [p- [2-(二甲氨基)乙氧基] 苄基] 维拉曲米盐酸盐

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C20H26N2O4 ·HCl
化学文摘社编号:
分子量:
394.89
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

伊托必利 盐酸盐, ≥98% (HPLC)

SMILES string

Cl.COc1ccc(cc1OC)C(=O)NCc2ccc(OCCN(C)C)cc2

InChI key

ZTOUXLLIPWWHSR-UHFFFAOYSA-N

InChI

1S/C20H26N2O4.ClH/c1-22(2)11-12-26-17-8-5-15(6-9-17)14-21-20(23)16-7-10-18(24-3)19(13-16)25-4;/h5-10,13H,11-12,14H2,1-4H3,(H,21,23);1H

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to tan

solubility

H2O: ≥48 mg/mL

originator

Abbott

storage temp.

2-8°C

Quality Level

General description

盐酸伊托必利是一种新型的促胃肠动力药。

Biochem/physiol Actions

伊托必利是乙酰胆碱酯酶 (AChE) 抑制剂和 D2 多巴胺受体拮抗剂。伊托必利是一种促胃动力药。
具有抗胆碱酯酶活性的多巴胺 D2 受体拮抗剂。
盐酸伊托必利通过阻断 D2 受体、突触后胆碱能神经上多巴胺的活性和诱导肌间神经丛中乙酰胆碱的释放,增强胃肠动力。它还能在乙酰胆碱酯酶的帮助下抑制释放的乙酰胆碱的水解。

Features and Benefits

该化合物由Abbott开发。要浏览其他药物开发化合物和批准的药物/候选药物列表,单击此处

pictograms

Environment

signalword

Warning

hcodes

Hazard Classifications

Aquatic Acute 1 - Aquatic Chronic 1

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Sanjay Bansal et al.
Drug delivery, 23(2), 437-451 (2014-05-29)
The objectives of present studies were to develop the systematically optimized multiple-unit gastroretentive microballoons, i.e. hollow microspheres of itopride hydrochloride (ITH) employing quality by design (QbD)-based approach. Initially, the patient-centric QTPP and CQAs were earmarked, and preliminary studies were conducted
[Effect of HSR-803 on gastrointestinal motility].
H Iwanaga et al.
Nihon Heikatsukin Gakkai zasshi, 25(6), 313-315 (1989-12-01)
N Kishibayashi et al.
Japanese journal of pharmacology, 66(4), 397-403 (1994-12-01)
KW-5092 ([1-[2-[[[5-(piperidinomethyl)-2- furanyl]methyl]amino]ethyl]-2-imidazolidinylidene] propanedinitrile fumarate) is a novel gastroprokinetic agent with acetylcholinesterase (AChE) inhibitory activity and acetylcholine release facilitatory activity. The present study used guinea pig ileal homogenates to examine the inhibitory effects of KW-5092 on the activities of AChE
E Takahara et al.
Journal of chromatography, 576(1), 174-178 (1992-04-15)
A method based on high-performance liquid chromatography using column-switching is described for the simultaneous determination of HSR-803 and its metabolites in human serum and urine. The system uses a six-port valve with a Nucleosil CN pre-column for on-line sample clean-up
Y Iwanaga et al.
Gastroenterology, 99(2), 401-408 (1990-08-01)
A novel water-soluble dopamine-2 antagonist, N-[4-[2-(dimethylamino) ethoxy]benzyl]-3,4-dimethoxybenzamide hydrochloride (HSR-803) was synthesized and assayed for its gastrointestinal smooth muscle stimulating activity in vivo and in vitro. In the in vivo study, gastrointestinal contractile activity was measured by means of chronically implanted

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持